Prostate specific antigen and gleason grade: an immunohistochemical study of prostate cancer.

[1]  A. R. Kendall,et al.  Immunoperoxidase localization of prostate‐specific antigen , 1982, The American journal of surgical pathology.

[2]  T. Stamey,et al.  Histologic differentiation, cancer volume, and pelvic lymph node metastasis in adenocarcinoma of the prostate , 1990, Cancer.

[3]  G. Murphy,et al.  Histologic grading of primary prostatic cancer: a new approach to an old problem. , 1980, The Journal of urology.

[4]  T. Wheeler.  Anatomic considerations in carcinoma of the prostate. , 1989, The Urologic clinics of North America.

[5]  R. Babaian,et al.  Prostate‐Specific Antigen and External Beam Radiation Therapy in Prostate Cancer , 1991, Cancer.

[6]  T. Stamey,et al.  Morphometric and clinical studies on 68 consecutive radical prostatectomies. , 1988, The Journal of urology.

[7]  M. Resnick,et al.  Tissue concentrations of prostate‐specific antigen in prostatic carcinoma and benign prostatic hyperplasia , 1991, International journal of cancer.

[8]  D. Tindall,et al.  In situ hybridization of prostate-specific antigen mRNA in human prostate. , 1990, The Journal of urology.

[9]  T. Stamey,et al.  Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the Prostate , 1987 .

[10]  T. Stamey,et al.  Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients. , 1989, The Journal of urology.

[11]  J. Epstein,et al.  Immunohistochemical localization of prostate-specific acid phosphatase and prostate-specific antigen in stage A2 adenocarcinoma of the prostate: prognostic implications. , 1984, Human pathology.

[12]  S. Kagawa,et al.  Prostatic origin of metastases: immunoperoxidase localization of prostate-specific antigen. , 1984, Urologia internationalis.

[13]  J. Trachtenberg,et al.  Adenocarcinoma of the Prostate , 1988 .

[14]  R. Stephenson,et al.  Prostate specific antigen in patients with clinical stage C prostate cancer: relation to lymph node status and grade. , 1991, The Journal of urology.

[15]  F. Mostofi,et al.  Grading of prostatic carcinoma. , 1975, Cancer chemotherapy reports.

[16]  H. Fritsche,et al.  Monoclonal prostate‐specific antigen in untreated prostate cancer. Relationship to clinical stage and grade , 1991, Cancer.

[17]  D E Johnson,et al.  Histologic grading study of prostate adenocarcinoma: The development of a new system and comparison with other methods—A preliminary study , 1982, Cancer.

[18]  P. Scardino,et al.  Relationship between clinical stage and histological zone of origin in early prostate cancer: morphometric analysis. , 1991, British journal of urology.

[19]  J. Masters,et al.  Immunocytochemical localisation of prostate-specific antigen: specificity and application to clinical practice. , 1985, British journal of urology.

[20]  J. Oesterling,et al.  Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia. , 1990, The Journal of urology.

[21]  J. Oesterling,et al.  Ability of preoperative serum prostate-specific antigen value to predict pathologic stage and DNA ploidy. Influence of clinical stage and tumor grade. , 1993, Urology.